Treatment results of breast cancer patients with locoregional recurrence after mastectomy

다국어 초록 (Multilingual Abstract)

Purpose: To analyze the results of locoregional and systemic therapy in the breast cancer patients with locoregional recurrence (LRR) after mastectomy.
Materials and Methods: Seventy-one patients who received radiotherapy for isolated LRR after mastectomy between January 1999 and December 2009 were retrospectively reviewed. Among the 71 patients, 59 (83.1%) underwent wide excision and radiotherapy and 12 (16.9%) received radiotherapy alone. Adjuvant hormonal therapy was given to 45 patients (63.4%). Oncologic outcomes including locoregional recurrence-free survival, disease-free survival (DFS), and overall survival (OS) and prognostic factors were analyzed.
Results: Median follow-up time was 49.2 months. Of the 71 patients, 5 (7%) experienced second isolated LRR, and 40 (56%) underwent distant metastasis (DM). The median DFS was 35.6 months, and the 3- and 5-year DFS were 49.1% and 28.6%, respectively. The median OS was 86.7 months, and the 5-year OS was 62.3%. Patients who received hormone therapy together showed better 5-year DFS and OS than the patients treated with locoregional therapy only (31.6% vs. 22.1%, p = 0.036; 66.5% vs. 55.2%, p = 0.022). In multivariate analysis, higher N stage at recurrence was a significant prognostic factor for DFS and OS. Disease free interval (≤30 months vs. >30 months) from mastectomy to LRR was also significant for OS. The patients who received hormone therapy showed superior DFS and showed trend to better OS.
Conclusion: DM was a major pattern of failure after the treatment of LRR after mastectomy. The role of systemic treatment for LRR after mastectomy should be investigated at prospective trials.

참고문헌 (Reference)

1 Aberizk WJ, "The use of radiotherapy for treatment of isolated locoregional recurrence of breast carcinoma after mastectomy" 58 : 1214-1218, 1986

2 Schwaibold F, "The results of radiation therapy for isolated local regional recurrence after mastectomy" 21 : 299-310, 1991

3 Schmoor C, "Role of isolated locoregional recurrence of breast cancer: results of four prospective studies" 18 : 1696-1708, 2000

4 Wallgren A, "Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII" 21 : 1205-1213, 2003

5 Chen KK, "Results of irradiation in the treatment of locoregional breast cancer recurrence" 56 : 1269-1273, 1985

6 김해영, "Results of Three-Dimensional Conformal Radiation Therapy for the Treatment of a Solitary Sternal Relapse of Breast Cancer" 대한방사선종양학회 26 (26): 91-95, 2008

7 Ha SW, "Radiotherapy in locoregional recurrent breast carcinoma" 6 : 203-210, 1988

8 Deutsch M, "Radiotherapy for postmastectomy local-regional recurrent breast cancer" 23 : 494-498, 2000

9 Deutsch M, "Radiation therapy for localregional recurrent breast carcinoma" 12 : 2061-2065, 1986

10 van Tienhoven G, "Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group" 35 : 32-38, 1999

11 Taghian A, "Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast And Bowel Project randomized clinical trials" 22 : 4247-4254, 2004

12 Eisenhauer EA, "New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)" 45 : 228-247, 2009

13 Haffty BG, "Molecular markers for prognosis after isolated postmastectomy chest wall recurrence" 100 : 252-263, 2004

14 Katz A, "Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation" 18 : 2817-2827, 2000

15 Buchanan CL, "Locoregional recurrence after mastectomy: incidence and outcomes" 203 : 469-474, 2006

16 Haylock BJ, "Locoregional first recurrence after mastectomy: prospective cohort studies with and without immediate chemotherapy" 46 : 355-362, 2000

17 Recht A, "Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group" 17 : 1689-1700, 1999

18 Nielsen HM, "Loco-regional recurrence after mastectomy in high-risk breast cancer: risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials" 79 : 147-155, 2006

19 Moran MS, "Local-regional breast cancer recurrence: prognostic groups based on patterns of failure" 8 : 81-87, 2002

20 Halverson KJ, "Isolated local-regional recurrence of breast cancer following mastectomy: radiotherapeutic management" 19 : 851-858, 1990

21 Kuo SH, "Chia-Hsien Cheng J. Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence" 72 : 1456-1464, 2008

22 Aebi S, "Chemotherapy prolongs survival for isolated local or regional recurrence of breast cancer: the CALOR trial (Chemotherapy as Adjuvant for Locally Recurrent breast cancer; IBCSG 27-02, NSABP B-37, BIG 1-02)" 72 (72): 2012

23 Magno L, "Analysis of prognostic factors in patients with isolated chest wall recurrence of breast cancer" 60 : 240-244, 1987

24 Waeber M, "Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observation" 14 : 1215-1221, 2003